LMED (LataMed AI) Total Stockholders Equity: $7.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMED LataMed AI Corp LMED
23 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is LataMed AI Total Stockholders Equity?

LataMed AI LMED -5.52% 23 Total Stockholders Equity is $7.05 Mil as of Jun. 2026. GuruFocus rates LMED with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

LataMed AI's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $7.05 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LataMed AI's Book Value per Share for the quarter that ended in Jun. 2026 was $0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LataMed AI's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.07.


LataMed AI  (OTCPK:LMED) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LataMed AI's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LataMed AI's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LataMed AI Total Stockholders Equity Related Terms


LataMed AI Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for LataMed AI's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI Total Stockholders Equity Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
Total Stockholders Equity
-0.50 -0.57 -0.63

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 -0.66 -0.63 7.14 7.05
LMED
23GF Score
LataMed AI Corp LMED
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $7.05 Mil mean?
LataMed AI (LMED) has a Total Stockholders Equity of $7.05 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LataMed AI and its competitors.
Is LataMed AI's Total Stockholders Equity too high?
LataMed AI's current Total Stockholders Equity is $7.05 Mil. Overall, LataMed AI has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Total Stockholders Equity compare to RYDE and RDZN?
LataMed AI's Total Stockholders Equity of $7.05 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Software company?
A good Total Stockholders Equity depends on the Software industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LataMed AI and its competitors. LataMed AI's current Total Stockholders Equity is $7.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMED) has a current Total Stockholders Equity of $7.05 Mil. The current Total Stockholders Equity is $7.05 Mil. LataMed AI's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For LataMed AI (LMED), the current Total Stockholders Equity is $7.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
23GF Score

Get the complete analysis for LMED

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price